Parallel Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-160
Closed -$2.07K 3549
2025
Q2
$2.07K Hold
160
﹤0.01% 3035
2025
Q1
$1.17K Sell
160
-71
-31% -$785 ﹤0.01% 3089
2024
Q4
$3.84K Sell
231
-1,229
-84% -$16.4K ﹤0.01% 2736
2024
Q3
$18.8K Hold
1,460
﹤0.01% 2134
2024
Q2
$16.3K Buy
1,460
+160
+12% +$1.86K ﹤0.01% 2093
2024
Q1
$16.1K Buy
1,300
+400
+44% +$6.67K ﹤0.01% 2096
2023
Q4
$23.9K Buy
+900
New +$26.3K ﹤0.01% 1823
2022
Q3
Sell
-265
Closed -$2K 3111
2022
Q2
$2K Hold
265
﹤0.01% 2525
2022
Q1
$3K Buy
+265
New +$3.39K ﹤0.01% 2434

Other funds holding AEHR

Parallel Advisors's AEHR Position: Q3 2025 in Review

Parallel Advisors sold out of Aehr Test Systems (AEHR) in Q3 2025, closing a stake of 160 shares — an estimated $2.07K sold.

Parallel Advisors first reported a position in AEHR in Q1 2022 and held it in 9 quarters. The position peaked at $23.9K in Q4 2023. 149 funds tracked by Wall St. Rank hold AEHR as of Q3 2025.

  • Parallel Advisors reported no remaining Aehr Test Systems position as of Q3 2025 after selling out during the quarter.
  • Parallel Advisors sold 160 Aehr Test Systems shares in Q3 2025, an estimated $2.07K.
  • Parallel Advisors first reported a position in Aehr Test Systems in Q1 2022 and held it in 9 quarters.
  • Parallel Advisors's Aehr Test Systems position peaked at $23.9K in Q4 2023.
  • 149 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2025.

Based on Parallel Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.